KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Change in Cash: 2009-2024

Historic Change in Cash for Nektar Therapeutics (NKTR) over the last 16 years, with Dec 2024 value amounting to $9.0 million.

  • Nektar Therapeutics' Change in Cash fell 190.18% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 131.38%. This contributed to the annual value of $9.0 million for FY2024, which is 116.95% up from last year.
  • Nektar Therapeutics' Change in Cash amounted to $9.0 million in FY2024, which was up 116.95% from -$53.0 million recorded in FY2023.
  • In the past 5 years, Nektar Therapeutics' Change in Cash registered a high of $102.6 million during FY2020, and its lowest value of -$173.7 million during FY2021.
  • Its 3-year average for Change in Cash is $6.3 million, with a median of $9.0 million in 2024.
  • As far as peak fluctuations go, Nektar Therapeutics' Change in Cash spiked by 204.11% in 2020, and later crashed by 269.35% in 2021.
  • Yearly analysis of 5 years shows Nektar Therapeutics' Change in Cash stood at $102.6 million in 2020, then plummeted by 269.35% to -$173.7 million in 2021, then skyrocketed by 136.27% to $63.0 million in 2022, then slumped by 184.04% to -$53.0 million in 2023, then surged by 116.95% to $9.0 million in 2024.